Advances in Risk Assessment of Post-stenting Ischemic and Bleeding Events Caused by Dual Antiplatelet Therapy

doi:10.12114/j.issn.1007-9572.2019.00.250

Abstract

Abstract: The number of patients with coronary atherosclerotic heart disease in China is increasing rapidly.As interventional techniques continue to be improved，the application of drug-eluting stent placement in this group is becoming wider.Dual antiplatelet therapy（DAPT） reduces the risk of postoperative stent thrombosis，but increases the risk of bleeding.Related guidelines recommend that doctors develop personalized DAPT regimens，and perform an assessment of the risks of bleeding and ischemic events prior to develop the optimal DAPT regimen for a patient.In recent years，there has been a continuous analysis of the clinical features of patients receiving DAPT after stent implantation，and based on the results，risk assessment tools for ischemic events after stent implantation and bleeding events caused by DAPT have been developed.This article reviews the published high-quality risk assessment tools to provide help for further clinical application and research of such tools.

Key words: Coronary disease；Drug-eluting stents；Coronary artery bypass, off-pump；Platelet aggregation inhibitors；Hemorrhage；Myocardial ischemia

摘要： 随着我国冠状动脉粥样硬化性心脏病患病人数的迅速增长和介入治疗技术的不断改良，越来越多的患者接受了药物洗脱支架植入术。双联抗血小板治疗可以降低术后支架内血栓形成发生风险，同时也增加了出血事件的发生风险。相关指南建议医生个性化制定双联抗血小板治疗疗程。日常治疗决策过程中，制定特定患者双联抗血小板治疗最佳疗程前需对其出血事件和缺血事件发生风险进行评估。近年来，不断有学者对支架植入术后接受双联抗血小板治疗患者的临床特征进行汇总分析，基于分析结果开发支架植入术后缺血事件和双联抗血小板治疗出血事件发生风险评估工具。本文主要就已发表的高质量风险评估工具进行综述，旨在为临床医生的后期应用与研究提供帮助。

关键词: 冠心病；药物洗脱支架；冠状动脉旁路移植术, 非体外循环；血小板聚集抑制剂；出血；心肌缺血

ZHOU Suzhe,PAN Zhigang. Advances in Risk Assessment of Post-stenting Ischemic and Bleeding Events Caused by Dual Antiplatelet Therapy　[J]. Chinese General Practice, 2019, 22(36): 4415-4419. DOI: 10.12114/j.issn.1007-9572.2019.00.250.
周溯喆,潘志刚. 支架植入术后缺血事件和双联抗血小板治疗后出血事件风险评估的研究进展[J]. 中国全科医学, 2019, 22(36): 4415-4419. DOI: 10.12114/j.issn.1007-9572.2019.00.250.

References

［1］陈伟伟，高润霖，刘力生，等．《中国心血管病报告2017》概要［J］．中国循环杂志，2018，33（1）：1-8．DOI：10.3969/j.issn.1000-3614.2018.01.001.
［2］中华医学会心血管病学分会介入心脏病学组，中国医师协会心血管内科医师分会血栓防治专业委员会，中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南（2016）［J］．中华心血管病杂志，2016，44（5）：382-400．DOI：10.3760/cma.j.issn.0253-3758.2016.05.006.
Chinese Medical Association Cardiovascular Diseases Interventional Cardiology Group，Chinese Medical Association Cardiovascular Physician Branch Committee of Thrombosis Prevention，Chinese Journal of Cardiovascular Diseases Editorial Board.Chinese Percutaneous Coronary Intervention Therapy Guide （2016）［J］．Chinese Journal of Cardiovascular Diseases，2016，44（5）：382-400．DOI：10.3760/cma.j.issn.0253-3758.2016.05.006.
［3］VALGIMIGLI M，BUENO H，BYRNE R A，et al．2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS：The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology （ESC） and of the European Association for Cardio-Thoracic Surgery （EACTS）［J］．Eur Heart J，2018，39（3）：213-260．DOI：10.1093/eurheartj/ehx419.
［4］梁峰，方全，沈珠军，等．2016年ACC/AHA更新冠心病患者双联抗血小板治疗持续时间指南介绍［J］．中华心脏与心律电子杂志，2016，4（4）：193-200．DOI：10.3877/cma.j.issn.2095-6568.2016.04.001.
［5］王国位，甘继宏，钟文波，等．冠心病患者DES植入后双联抗血小板服用时间与预后的研究［J］．中国循证心血管医学杂志，2018，10（3）：283-287．DOI：10.3969/j.issn.1674-4055.2018.03.07.
WANG G W，GAN J H，ZHONG W B，et al．The follow-up study of dual antiplatelet therapy （DAPT） duration and the prognosis of coronary heart diseases patients after drug-eluting stent （DES） implantation［J］．Chinese Journal of Evidence-Bases Cardiovascular Medicine，2018，10（3）：283-287．DOI：10.3969/j.issn.1674-4055.2018.03.07.
［6］GWON H C，HAHN J Y，PARK K W，et al．Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents：the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting （EXCELLENT） randomized，multicenter study［J］．Circulation，2012，125（3）：505-513．DOI：10.1161/CIRCULATIONAHA.111.059022.
［7］KIM B K，HONG M K，SHIN D H，et al．A new strategy for discontinuation of dual antiplatelet therapy：the RESET Trial （REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation）［J］．J Am Coll Cardiol，2012，60（15）：1340-1348．DOI：10.1016/j.jacc.2012.06.043.
［8］CASSESE S，BYRNE R A，TADA T，et al．Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era：a meta-analysis of randomized trials［J］．Eur Heart J，2012，33（24）：3078-3087．DOI：10.1093/eurheartj/ehs318.
［9］PANDIT A，GIRI S，HAKIM F A，et al．Shorter （≤6 months） versus longer（≥12 months） duration dual antiplatelet therapy after drug eluting stents：a meta-analysis of randomized clinical trials［J］．Catheter Cardiovasc Interv，2015，85（1）：34-40．DOI：10.1002/ccd.25520.
［10］DANGAS G D，CLAESSEN B E，MEHRAN R，et al．Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes［J］．JACC Cardiovasc Interv，2012，5（11）：1097-1105．DOI：10.1016/j.jcin.2012.07.012.
［11］YEH R W，SECEMSKY E A，KEREIAKES D J，et al．Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention［J］．JAMA，2016，315（16）：1735-1749．DOI：10.1001/jama.2016.3775.
［40］APPLETON S，BIERMANN S，HAMILTON-BRUCE A，et al．Functional health literacy is significantly associated with risk factors for stroke in a population sample［J］．Int J Stroke，2015，10（3）：E23．DOI：10.1111/ijs.12425.
［41］POLUNINA N V，KOSTENKO E V.An effect of education and health literacy on the efficacy of rehabilitation of post-stroke patients［J］．Zh Nevrol Psikhiatr Im S S Korsakova，2017，117（3. Vyp. 2）：48-54．DOI：10.17116/jnevro20171173248-54.
［42］SANDERS K，SCHNEPEL L，SMOTHERMAN C，et al．Assessing the impact of health literacy on education retention of stroke patients［J］．Prev Chronic Dis，2014，11：130259．DOI：10.5888/pcd11.130259.
［43］HUANG Y J，CHEN C T，LIN G H，et al．Evaluating the European health literacy survey questionnaire in patients with stroke：a latent trait analysis using rasch modeling［J］．Patient，2018，11（1）：83-96．DOI：10.1007/s40271-017-0267-3.
［44］GANZER C A，INSEL K C，RITTER L S.Associations between working memory，health literacy，and recall of the signs of stroke among older adults［J］．J Neurosci Nurs，2012，44（5）：236-243．DOI：10.1097/JNN.0b013e3182666231.
［45］齐艳，孙文霞，赵晓云.健康素养对脑卒中患者教育记忆保持力的影响［J］．中国实用护理杂志，2016，32（8）：590-593．DOI：10.3760/cma.j.issn.1672-7088.2016.08.007.
［46］AGUIRRE A C，EBRAHIM N，SHEA J A.Performance of the English and Spanish S-TOFHLA among publicly insured Medicaid and Medicare patients［J］．Patient Educ Couns，2005，56（3）：332-339．DOI：10.1016/j.pec.2004.03.007.
［47］SCHRINER M T.Health literacy and media preferences with stroke survivors［D］．Lawrence：University of Kansas，2011.
［48］KAMAL A K，MUQEET A，FARHAT K，et al．Using a tailored health information technology-driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease（Talking Rx）-study protocol for a randomized controlled trial［J］．Trials，2016，17（1）：121．DOI：10.1186/s13063-016-1244-1.
［49］XI E.Evidence-based project to improve stroke unit outcomes：assessment of health literacy to individualize stroke education［J］．Braz J Microbiol，2013，44（1）：165-170.
［50］RYMER J，MCCOY L，ANSTROM K，et al．Abstract 206：impact of inpatient evaluation of health literacy on outcomes in post-MI patients［J］．Meditsinskaia Parazitologiia I Parazitarnye Bolezni，2016，46（1）：41-45.
［51］GLANZ K，BISHOP D B.The role of behavioral science theory in development and implementation of public health interventions［J］．Annu Rev Public Health，2010，31：399-418．DOI：10.1146/annurev.publhealth.012809.103604.
［12］CUTLIP D E，WINDECKER S，MEHRAN R，et al．Clinical end points in coronary stent trials：a case for standardized definitions［J］．Circulation，2007，115（17）：2344-2351．DOI：10.1161/CIRCULATIONAHA.106.685313.
［13］An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction［J］．N Engl J Med，1993，329（10）：673-682．DOI：10.1056/NEJM199309023291001.
［14］UEDA P，JERNBERG T，JAMES S，et al．External validation of the DAPT score in a nationwide population［J］．J Am Coll Cardiol，2018，72（10）：1069-1078．DOI：10.1016/j.jacc.2018.06.023.
［15］BABER U，MEHRAN R，GIUSTINO G，et al．Coronary thrombosis and major bleeding after PCI with drug-eluting stents：risk scores from PARIS［J］．J Am Coll Cardiol，2016，67（19）：2224-2234．DOI：10.1016/j.jacc.2016.02.064.
［16］THYGESEN K，ALPERT J S，JAFFE A S，et al．Third universal definition of myocardial infarction［J］．J Am Coll Cardiol，2012，60（16）：1581-1598．DOI：10.1016/j.jacc.2012.08.001.
［17］MEHRAN R，RAO S V，BHATT D L，et al．Standardized bleeding definitions for cardiovascular clinical trials：a consensus report from the Bleeding Academic Research Consortium［J］．Circulation，2011，123（23）：2736-2747．DOI：10.1161/CIRCULATIONAHA.110.009449.
［18］COSTA F，VAN KLAVEREN D，JAMES S，et al．Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy （PRECISE-DAPT） score：a pooled analysis of individual-patient datasets from clinical trials［J］．Lancet，2017，389（10073）：1025-1034．DOI：10.1016/S0140-6736（17）30397-5.
［19］ABU-ASSI E，RAPOSEIRAS-ROUBIN S，COBAS-PAZ R，et al．Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients［J］．EuroIntervention，2018，13（16）：1914-1922．DOI：10.4244/EIJ-D-17-00550.
［20］赵雪燕，杨进刚，范肖雪，等．PARIS出血评分对急性心肌梗死药物支架植入术后患者院内出血的预测价值——中国急性心肌梗死注册研究［J］．中国循环杂志，2018，33（2）：110-116．DOI：10.3969/j.issn.1000-3614.2018.02.003.
［21］SONG L，GUAN C，YAN H，et al．Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations［J］．Catheter Cardiovasc Interv，2018，91（S1）：573-581．DOI：10.1002/ccd.27468.